Product nameAnti-CRLS1 antibody
See all CRLS1 primary antibodies
DescriptionGoat polyclonal to CRLS1
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat, Cow, Dog, Pig
- HEK293 cell lysate
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.30
Preservative: 0.02% Sodium azide
Constituents: 99% Tris buffered saline, 0.5% BSA
Concentration information loading...
PurityImmunogen affinity purified
Purification notesab126849 was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Pathways and Processes
- Metabolic signaling pathways
- Lipid and lipoprotein metabolism
- Fatty acids
Our Abpromise guarantee covers the use of ab126849 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 0.2 - 0.6 µg/ml. Detects a band of approximately 30 kDa (predicted molecular weight: 32 kDa).
1 hour primary incubation is recommended for this product.
FunctionCatalyzes the reversible phosphatidyl group transfer from one phosphatidylglycerol molecule to another to form cardiolipin (CL) (diphosphatidylglycerol) and glycerol.
Tissue specificityHighly expressed in tissues such as heart, skeletal muscle and liver.
Sequence similaritiesBelongs to the CDP-alcohol phosphatidyltransferase class-I family.
Cellular localizationMitochondrion inner membrane.
- Information by UniProt
- 0610009I22Rik antibody
- 4930557M15Rik antibody
- 5730490M08 antibody
Anti-CRLS1 antibody (ab126849) at 0.2 µg/ml + HEK293 cell lysate in RIPA buffer at 35 µg
Developed using the ECL technique.
Predicted band size: 32 kDa
Observed band size: 30 kDa why is the actual band size different from the predicted?
Primary incubation with ab126849 was 1 hour.
ab126849 has not yet been referenced specifically in any publications.